Loading organizations...
§ Private Profile · Wakefield, MA, USA
Clinical-stage medical device company developing medical devices for uncontrolled hypertension, focused on renal denervation therapy.
Ablative Solutions is a clinical-stage medical device company based in San Jose, California, and Kalamazoo, Michigan, developing minimally invasive renal denervation therapies for the treatment of uncontrolled hypertension. Founded in 2011 by Tim Fischell and David Fischell, the enterprise created the Peregrine System, which uses a percutaneous catheter to deliver dehydrated alcohol perivascularly to deactivate sympathetic nerves surrounding the renal arteries. The proprietary technology previously received Breakthrough Device Designation from the Food and Drug Administration for treating drug-resistant hypertension and recently demonstrated positive six-month safety and efficacy data. To support its ongoing TARGET BP global clinical trials and pursue regulatory approvals, the firm has secured over $130 million in total venture funding. This capitalization includes a $77 million Series D financing round backed by institutional investors such as Gilde Healthcare, Novalis LifeSciences, and BioStar Capital.
Ablative Solutions has raised $91.8M across 3 funding rounds.
Ablative Solutions has raised $91.8M in total across 3 funding rounds.
Ablative Solutions has raised $91.8M in total across 3 funding rounds.
Ablative Solutions's investors include Michael Fulton, Michigan Accelerator Fund, Novus Biotechnology, BioStar Ventures, Steven L. Almany.
Ablative Solutions has raised $91.8M across 3 funding rounds. Most recently, it raised $77.0M Series D in January 2019.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 3, 2019 | $77M Series D | — | Michael Fulton, Michigan Accelerator Fund, Novus Biotechnology | Announced |
| Feb 4, 2014 | $9.5M Series B | BioStar Ventures, Michigan Accelerator Fund | — | Announced |
| Jun 19, 2012 | $5.3M Series A | Steven L. Almany, Michigan Accelerator Fund | — | Announced |